Transient Anti-Drug Antibodies and Their Impact on Markers of Inflammation: Longitudinal Data From a 7-Year Study of Certolizumab Pegol in Crohnʼs Disease Patients: 1830
2015
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI